Therefore, our findings suggest that the CBD: THC combination not only hinders pro-survival PI3K/AKT/m-TOR signaling but also reactivates intrinsic tumor suppressor pathways, offering a dual-targeted approach for the treatment of ovarian cancer. The gene discussed is AKT1; the disease is ovarian carcinoma.